ABOUT ELITE
Overview
Our Facility
Management & Key Employees
Our Board
Careers
PRODUCTS
PIPELINE
Generic
Branded
TECHNOLOGY
Technology Overview
How It Works
One Bead System
Two Bead System
INVESTOR RELATIONS
Press Releases
Events & Presentations
SEC Filings
Shareholder Meeting
Governance Documents
Investor Contacts
Email Alerts
HOME
|
CAREERS
|
CONTACT
|
NEWS
|
Skip to content
About Elite
Overview
Management & Key Employees
Our Board
Careers
Products
Pipeline
Generic
Branded
Technology
Technology Overview
How It Works
One Bead System
Two Bead System
Investor Relations
Press Releases
Events & Presentations
SEC Filings
Shareholder Meeting
Governance Documents
Investor Contacts
Email Alerts
Investor Relations
Press Releases
Events &Presentations
SEC Filings
ShareholderMeeting
GovernanceDocuments
Investor Contacts
Email Alerts
Press Releases
Select:
Show All
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
Archived
Nov 03, 2008
ELITE PHARMACEUTICALS ELECTS WALL STREET VETERAN JERRY TREPPEL TO THE BOARD OF DIRECTORS
Sep 29, 2008
ELITE ANNOUNCES DRUG APPLICATION FILING FOR SYNTHETIC NARCOTIC ANALGESIC ACCEPTED BY FDA
Sep 15, 2008
ELITE ANNOUNCES CLOSING OF PRIVATE PLACEMENT
Jul 08, 2008
ELITE PHARMACEUTICALS FILES ITS FORM 10-K FOR THE FISCAL YEAR ENDED MARCH 31, 2008 WITH THE SEC
Apr 19, 2008
ELITE PHARMACEUTICALS APPOINTS CHIEF SCIENTIFIC OFFICER
Mar 31, 2008
Elite Pharmaceuticals, Inc. Reports Opioid Abuse-Resistant Products Gaining Momentum
Mar 03, 2008
Elite Pharmaceuticals, Inc. to Present at the Susquehanna Financial Healthcare Conference
Feb 14, 2008
Elite Pharmaceuticals, Inc. to Present Clinical Data at the American Academy of Pain Medicine's 24th Annual Meeting
Jan 23, 2008
Elite Pharmaceuticals, Inc. Retains The Global Consulting Group as Strategic Communications Advisors
Jan 08, 2008
Elite Pharmaceuticals Appoints Stuart Apfel, M.D. as Chief Medical Officer
17
18
19
20
21
22
23
24
25
26
27
<<
<
>
>>
Back to top
Privacy
